CN102526403A - 一种治疗面神经麻痹症的中药制剂 - Google Patents
一种治疗面神经麻痹症的中药制剂 Download PDFInfo
- Publication number
- CN102526403A CN102526403A CN2012100290397A CN201210029039A CN102526403A CN 102526403 A CN102526403 A CN 102526403A CN 2012100290397 A CN2012100290397 A CN 2012100290397A CN 201210029039 A CN201210029039 A CN 201210029039A CN 102526403 A CN102526403 A CN 102526403A
- Authority
- CN
- China
- Prior art keywords
- chinese medicinal
- medicinal preparation
- paralysis
- radix
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 208000006373 Bell palsy Diseases 0.000 title abstract description 3
- 239000003814 drug Substances 0.000 claims abstract description 39
- 208000004929 Facial Paralysis Diseases 0.000 claims abstract description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 14
- 239000004863 Frankincense Substances 0.000 claims abstract description 12
- 229940079593 drug Drugs 0.000 claims abstract description 11
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 7
- 239000002674 ointment Substances 0.000 claims abstract description 6
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 4
- 208000036826 VIIth nerve paralysis Diseases 0.000 claims description 12
- 241000717739 Boswellia sacra Species 0.000 claims description 10
- 241001057584 Myrrha Species 0.000 claims description 9
- 241000756943 Codonopsis Species 0.000 claims description 6
- 239000009286 sanguis draxonis Substances 0.000 claims description 6
- 241000349731 Afzelia bipindensis Species 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 5
- 241000283956 Manis Species 0.000 claims description 5
- 241000972155 Moschus Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 11
- 201000010099 disease Diseases 0.000 abstract description 7
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 2
- 208000026435 phlegm Diseases 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 2
- 240000007551 Boswellia serrata Species 0.000 abstract 2
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 2
- 240000007311 Commiphora myrrha Species 0.000 abstract 2
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 2
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 241000510667 Conioselinum Species 0.000 abstract 1
- 241000402754 Erythranthe moschata Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000282346 Meles meles Species 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 241001180876 Saposhnikovia Species 0.000 abstract 1
- 241000246044 Sophora flavescens Species 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 241000301400 Trogopterus Species 0.000 abstract 1
- 240000001398 Typha domingensis Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 210000003608 fece Anatomy 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 229940041616 menthol Drugs 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 230000006870 function Effects 0.000 description 16
- 206010033799 Paralysis Diseases 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 230000002708 enhancing effect Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 206010008190 Cerebrovascular accident Diseases 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000007830 nerve conduction Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 206010013887 Dysarthria Diseases 0.000 description 2
- 206010015995 Eyelid ptosis Diseases 0.000 description 2
- 244000153234 Hibiscus abelmoschus Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 201000003004 ptosis Diseases 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- JVXZRQGOGOXCEC-UHFFFAOYSA-N scutellarein Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C(O)=C(O)C=C2O1 JVXZRQGOGOXCEC-UHFFFAOYSA-N 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- WTQYWNWRJNXDEG-UHFFFAOYSA-N 6-Hydroxy-hyoscyamin Natural products CN1C(C2)CC(O)C1CC2OC(=O)C(CO)C1=CC=CC=C1 WTQYWNWRJNXDEG-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010002027 Amyotrophy Diseases 0.000 description 1
- 208000025679 Bell phenomenon Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 244000021150 Orbignya martiana Species 0.000 description 1
- 235000014643 Orbignya martiana Nutrition 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 241000598137 Pedunculus Species 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 208000008630 Sialorrhea Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- WTQYWNWRJNXDEG-LEOABGAYSA-N anisodamine Chemical compound C1([C@@H](CO)C(=O)O[C@@H]2C[C@H]3[C@@H](O)C[C@@H](C2)N3C)=CC=CC=C1 WTQYWNWRJNXDEG-LEOABGAYSA-N 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000019564 dysgeusia Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 230000008921 facial expression Effects 0.000 description 1
- 210000001097 facial muscle Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 208000021090 palsy Diseases 0.000 description 1
- 230000000590 parasiticidal effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 208000026473 slurred speech Diseases 0.000 description 1
- 210000001584 soft palate Anatomy 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗面神经麻痹症的中药制剂,其特征在于它是由下述配比的药物:内服药:党参10~15g、黄芪8~10g、白术6~8g、鸡血藤6~8g、防风6~8g、川芎6~8g、乳香4~6g、没药6~8g、穿山甲4~6g,蒲黄4~6g、五灵脂6~8g、玄参8~10g、陈皮6~8g、苦参6~8g、血竭6~8g、茯苓6~8g、甘草4~6g。外用药:麝香0.2g、薄荷脑0.5g、乳香5g、没药5g均研粉后用獾油调成膏剂敷患处。本发明的有益效果是:以扶正、祛风、祛痰、通络为治则,临床上常根据不同症型辨证施治。疗效好、治愈率高,成本低且无毒副作用,值得推广使用,该药对周围性面瘫与中枢性面瘫均有效。
Description
技术领域
本发明涉及一种治疗面神经麻痹症的中药制剂。
背景技术
众所周知,面部神经麻痹又叫面瘫,该病起病急骤,其表现为口眼歪斜、言语不清、口角流涎等,中医称之为中风。现代医学认为该病是由于脑血管阻塞、面部血液循环不畅、患部神经传导失调所致,面神经瘫痪分为周围性面瘫与中枢性面瘫瘫,前者大多原因不明,与寒冷,风吹,病毒感染有关,可能因患部神经传导失调所致,后者为脑血管意外引起的合并症,治疗不及时得当,则给患者带来痛苦。
发明内容
本发明所要解决的技术问题是为了克服技术上的不足,提供疗效好、疗程短,治愈率高,成本低,无毒副作用的一种治疗面神经麻痹症的中药制剂。
为了上述目的,一种治疗面神经麻痹症的中药制剂,其特征在于中药的原料药组成为:内服药:党参10~15g、黄芪8~10g、白术6~8g、鸡血藤6~8g、防风6~8g、川芎6~8g、乳香4~6g、没药4~6g、穿山甲4~6g,蒲黄4~6g、五灵脂6~8g、玄参8~10g、陈皮6~8g、苦参6~8g、血竭6~8g、茯苓6~8g、甘草4~6g。外用药:麝香0.2g、薄荷脑0.5g、乳香5g、没药5g均研粉后用獾油调成膏剂敷患处。
本发明的有益效果是:以扶正、祛风、祛痰、通络为治则。临床上常根据不同症型辨证施治。该发明中药适用于治疗周围性面瘫与中枢性面瘫。
本发明中药方中党参为上品,功能主治:补中益气,健脾益肺之功效。现代医药研究,党参含多种糖类、酚类、甾醇、挥发油、黄芩素葡萄糖甙、皂甙及微量生物碱,具有增强免疫力、扩张血管、降压、改善微循环、增强造血功能。黄芪味:甘,微温。功能主治:益气固表、敛汗固脱、托疮生肌、利水消肿之功效。白术的功能主治:健脾益气,燥湿利水,止汗,安胎。鸡血藤味苦甘性温,归肝肾经。活血舒筋;养血调经。现代医药研究:具有增强造血系统功能。防风,又名铜芸、百枝。其味辛甘,性微温而润,为“风药中之润剂”,功能主治:祛风解表,胜湿止痛,止痉定搐。能止血,又能通经。川芎功能主治:活血行气,祛风止痛。用于安抚神经,正头风头痛,症瘕腹痛。乳香,味辛、苦,性温。入心、肝、脾经。功能主治:调气活血,定痛,追毒。治气血凝滞、心腹疼痛,痈疮肿毒……。《珍珠囊》:乳香定诸经之痛。没药味苦,平,无毒。没药配乳香,活血散瘀、行气舒筋,配穿山甲,活血散瘀、消肿止痛。五灵脂味甘,性温。功能主治:活血散瘀,炒炭止血,其苦泄温通,“通利气脉”,“通则不痛。”故《本草经疏》谓之“血滞经脉,气不得行,攻刺疼痛等证,在所必用”。蒲黄性平,味甘。归肝、心包经。功能主治:止血,化瘀,通淋。玄参味甘、苦、咸,性微寒。功能主治:清热凉血,泻火解毒,滋阴。陈皮功能主治:脾胃气滞之脘腹胀满或疼痛、消化不良。湿浊阻中之胸闷腹胀、纳呆便溏。苦参性寒,功能主治:清热燥湿,杀虫的功效。血竭为棕榈科植物麒麟竭果实及树干中的树脂,功能主治:活血散瘀,定痛,外用可止血生肌,敛疮。茯苓味甘、淡、性平,入药具有利水渗湿、益脾和胃、宁心安神之功用。现代医学研究:茯苓能增强机体免疫功能,茯苓多糖有明显的抗肿瘤及保肝脏作用。甘草性平、味甘,归十二经。功效主治:补脾益气,清热解毒,缓急止痛,调和诸药。外用药中的獾油具有清热解毒,消肿止痛的功效。以上诸药相配,治疗该病,相得益彰。
本发明遵循中医的处方用药原则,分内服药和外用药。本发明经临床验证:本发明中药治疗本病,经统计治疗周围性麻痹患者和中枢性麻痹,共治愈64例、好转6例,未愈2例,治愈率88.9%,有效率97.2%,未愈2.7%。无毒副作用。
具体实施方式
下面结合实施病例对本发明作进一步描述:
实施例1:一种治疗面神经麻痹症的中药制剂,其特征在于按下述配比称取原料药物:内服药:党参10~15g、黄芪8~10g、白术6~8g、鸡血藤6~8g、防风6~8g、川芎6~8g、乳香4~6g、没药6~8g、穿山甲4~6g,蒲黄4~6g、五灵脂6~8g、玄参8~10g、陈皮6~8g、苦参6~8g、血竭6~8g、茯苓6~8g、甘草4~6g。外用药:麝香0.2g、薄荷脑0.5g、乳香5g、没药5g均研粉后用獾油调成膏剂敷患处。
实施例2:一种治疗面神经麻痹症的中药制剂,其特征在于按下述配比称取原料药物:内服药:党参10~15g、黄芪10g、白术8g、鸡血藤6~8g、防风8g、川芎8g、乳香4g、没药6g、穿山甲4g,蒲黄8g、五灵脂6g、玄参10g、陈皮8g、苦参6g、血竭6g、茯苓6g、甘草4g。外用药同实施例1。
临床疗效总结:
一、本方多年来在临床应用广泛,治疗周围性麻痹患者39例、中枢性麻痹33例,其中男32例、女40例,年龄42~79岁,疗效频佳。
二、诊断标准:分为周围性面瘫与中枢性面瘫瘫,前者大多原因不明,与寒冷,风吹,病毒感染有关,可能因患部神经传导失调所致,后者为脑血管意外引起的合并症,表现为病侧面部表情肌麻痹,额纹消失或表浅,不能皱额蹙眉,眼裂不能闭合或闭合不全,试闭眼时,瘫痪侧眼球向上方转动,露出白色巩膜,称贝耳现象。病侧鼻唇沟变浅,口角下垂,面颊部被牵向健侧,闭眼、露齿、鼓颊、吹口哨等动作失灵,或完全不能完成。因颊肌瘫痪而食物易滞留于病侧齿颊之间。泪点随下睑而外翻,使泪液不能正常吸收而致外溢。如侵及鼓束神经时,会出现舌前2/3味觉障碍。
三、服药方法:内服药,水煎服,每剂200ml,每日早、晚2次口服,每次100ml,10天为1疗程。外用药均研粉后,每剂用20ml獾油调成膏剂敷患处,每日1次,每次2小时。
四、疗效评定:
治愈:临床症状完全消失。
好转:临床症状改善。
未愈:临床症状无变化或加重。
五、治疗效果:本发明中药治疗本病,经统计治疗周围性麻痹患者和中枢性麻痹,共治愈64例、好转6例,未愈2例,治愈率88.9%,有效率97.2%,未愈2.7%。
六、典型病例
1、常XX,女,61岁,于2010年8月就诊,因面部表情肌麻痹经用土方效果不佳。查体:面部周围性面瘫,鼻唇沟变浅,口角下垂,左指鼻试验欠准,右巴彬斯基征阴性。头部CT扫描:未见异常。患者要求内服外用本发明中药10剂,临床症状完全消失,未再复发。
2、王XX,女,48岁。于2010年6月就诊,以口角歪斜7天经在社区医院用山莨菪碱片口服效果不佳。查体:左鼻唇沟稍浅,伸舌轻偏右,头颅CT:左侧大脑脚片状密度不均、边界不清的高度影,内部散在钙化点。患者要求内服外用本发明中药20剂,临床症状完全消失。未再复发。
3、董X,男,78岁。家人发现,双眼发呆,左右转动不动,次日发现口角左斜并流口水10天,经服用银杏叶片7天效果不佳。查体:双眼外展力弱,右侧面肌、斜方肌无力,双侧软腭提举力弱,构音困难,伸舌偏右,无肌萎缩。患者要求内服外用本发明中药30剂,临床症状完全消失,未再复发。
Claims (1)
1.本发明涉及一种治疗面神经麻痹症的中药制剂,其特征在于它是由下述配比的药物:内服药:党参10~15g、黄芪8~10g、白术6~8g、鸡血藤6~8g、防风6~8g、川芎6~8g、乳香4~6g、没药4~6g、穿山甲4~6g,蒲黄4~6g、五灵脂6~8g、玄参8~10g、陈皮6~8g、苦参6~8g、血竭6~8g、茯苓6~8g、甘草4~6g。外用药:麝香0.2g、薄荷脑0.5g、乳香5g、没药5g均研粉后用獾油调成膏剂敷患处。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210029039.7A CN102526403B (zh) | 2012-02-05 | 2012-02-05 | 一种治疗面神经麻痹症的中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210029039.7A CN102526403B (zh) | 2012-02-05 | 2012-02-05 | 一种治疗面神经麻痹症的中药制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102526403A true CN102526403A (zh) | 2012-07-04 |
CN102526403B CN102526403B (zh) | 2014-04-30 |
Family
ID=46335223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210029039.7A Expired - Fee Related CN102526403B (zh) | 2012-02-05 | 2012-02-05 | 一种治疗面神经麻痹症的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102526403B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104352661A (zh) * | 2014-11-17 | 2015-02-18 | 王旭东 | 一种治疗面神经麻痹症的中药药水及制备方法 |
CN104958542A (zh) * | 2015-08-05 | 2015-10-07 | 王曰军 | 一种用于治疗面神经麻痹的中药制剂及制备方法 |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1393235A (zh) * | 2001-06-26 | 2003-01-29 | 利津县第二人民医院 | 治疗面神经炎膏药及其制备方法 |
CN101274063A (zh) * | 2008-05-21 | 2008-10-01 | 王小兵 | 一种治疗面神经麻痹外用的膏药及其制备方法 |
CN101543558A (zh) * | 2008-03-28 | 2009-09-30 | 天科仁祥技术(北京)有限责任公司 | 一种用于治疗面神经麻痹的药物组合及其制备方法 |
CN101584813A (zh) * | 2008-05-25 | 2009-11-25 | 王玉兰 | 一种治疗面神经麻痹的中药 |
CN101703701A (zh) * | 2009-12-03 | 2010-05-12 | 秦开锋 | 一种治疗面神经麻痹的药物 |
CN101744906A (zh) * | 2008-12-01 | 2010-06-23 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备治疗面神经麻痹药物中的应用 |
CN101757535A (zh) * | 2008-12-02 | 2010-06-30 | 李琪 | 一种治疗脑血管意外后遗症的中药 |
CN101926903A (zh) * | 2010-09-02 | 2010-12-29 | 姬利亚 | 用于治疗面神经麻痹的中药制剂 |
CN101940675A (zh) * | 2010-09-10 | 2011-01-12 | 重庆市南川区金佛山中药材品种培育研究所 | 治疗面神经炎的中草药 |
CN101991739A (zh) * | 2009-08-26 | 2011-03-30 | 周姗姗 | 治疗面部神经麻痹的中药制剂 |
CN102000150A (zh) * | 2009-09-02 | 2011-04-06 | 陈恒树 | 一种治疗面神经炎的外涂剂 |
CN102018848A (zh) * | 2009-09-09 | 2011-04-20 | 马黎晓 | 治疗面部神经麻痹的中药制剂 |
CN102125685A (zh) * | 2011-03-10 | 2011-07-20 | 李素英 | 治疗面神经麻痹的药物及其制作方法 |
-
2012
- 2012-02-05 CN CN201210029039.7A patent/CN102526403B/zh not_active Expired - Fee Related
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1393235A (zh) * | 2001-06-26 | 2003-01-29 | 利津县第二人民医院 | 治疗面神经炎膏药及其制备方法 |
CN101543558A (zh) * | 2008-03-28 | 2009-09-30 | 天科仁祥技术(北京)有限责任公司 | 一种用于治疗面神经麻痹的药物组合及其制备方法 |
CN101274063A (zh) * | 2008-05-21 | 2008-10-01 | 王小兵 | 一种治疗面神经麻痹外用的膏药及其制备方法 |
CN101584813A (zh) * | 2008-05-25 | 2009-11-25 | 王玉兰 | 一种治疗面神经麻痹的中药 |
CN101744906A (zh) * | 2008-12-01 | 2010-06-23 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备治疗面神经麻痹药物中的应用 |
CN101757535A (zh) * | 2008-12-02 | 2010-06-30 | 李琪 | 一种治疗脑血管意外后遗症的中药 |
CN101991739A (zh) * | 2009-08-26 | 2011-03-30 | 周姗姗 | 治疗面部神经麻痹的中药制剂 |
CN102000150A (zh) * | 2009-09-02 | 2011-04-06 | 陈恒树 | 一种治疗面神经炎的外涂剂 |
CN102018848A (zh) * | 2009-09-09 | 2011-04-20 | 马黎晓 | 治疗面部神经麻痹的中药制剂 |
CN101703701A (zh) * | 2009-12-03 | 2010-05-12 | 秦开锋 | 一种治疗面神经麻痹的药物 |
CN101926903A (zh) * | 2010-09-02 | 2010-12-29 | 姬利亚 | 用于治疗面神经麻痹的中药制剂 |
CN101940675A (zh) * | 2010-09-10 | 2011-01-12 | 重庆市南川区金佛山中药材品种培育研究所 | 治疗面神经炎的中草药 |
CN102125685A (zh) * | 2011-03-10 | 2011-07-20 | 李素英 | 治疗面神经麻痹的药物及其制作方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104352661A (zh) * | 2014-11-17 | 2015-02-18 | 王旭东 | 一种治疗面神经麻痹症的中药药水及制备方法 |
CN104958542A (zh) * | 2015-08-05 | 2015-10-07 | 王曰军 | 一种用于治疗面神经麻痹的中药制剂及制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102526403B (zh) | 2014-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103127378B (zh) | 一种治疗风湿性心脏病的中药组合物 | |
CN102240380B (zh) | 一种治疗老年血管性痴呆的中药制剂 | |
CN103071128A (zh) | 一种治疗痛经的外用贴膏 | |
CN102743540A (zh) | 联合降糖方 | |
CN103330805A (zh) | 一种治疗月经过多的中药组合物 | |
CN102772560B (zh) | 一种治疗放射性肺损伤的中药组合物 | |
CN102716334B (zh) | 一种驱寒化瘀的中药组合物 | |
CN102078517B (zh) | 一种治疗肿瘤的中药 | |
CN102526403B (zh) | 一种治疗面神经麻痹症的中药制剂 | |
CN103330835A (zh) | 一种治疗更年期综合症的中药组合物 | |
CN102743671A (zh) | 一种治疗脑震荡后遗症的中药组合物 | |
CN103083616B (zh) | 一种治疗卵巢囊肿的中药 | |
CN102188619A (zh) | 一种治疗放射性肺炎的中药 | |
CN103721082A (zh) | 一种治疗肩周炎的中药组合物 | |
CN103989998A (zh) | 一种治疗面神经麻痹症的中药制剂 | |
CN103893332A (zh) | 一种治疗胃炎的中药 | |
CN104667129B (zh) | 一种治疗风湿性心脏病的药物 | |
CN103110710B (zh) | 治疗自汗的中药丸剂 | |
CN102988890A (zh) | 治疗黄褐斑的纯中药制剂 | |
CN103263645B (zh) | 一种治疗胃炎、胃溃疡的药物 | |
CN102698102A (zh) | 一种治疗慢性喉炎的中药组合物 | |
CN106177572A (zh) | 一种治疗再生障碍性贫血的中药汤剂 | |
CN102716379A (zh) | 一种治疗强直性脊柱炎的中药组合物 | |
CN105267836A (zh) | 一种治疗冠心病中药 | |
CN101837115B (zh) | 一种促进腰椎间盘突出症复位后恢复的蒸敷中药药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140430 Termination date: 20150205 |
|
EXPY | Termination of patent right or utility model |